Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Mangoceuticals Inc MGRX

Mangoceuticals, Inc. is focused on developing men’s and women’s health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:MGRX)

Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu

GlobeNewswire May 27, 2025

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division

GlobeNewswire April 25, 2025

CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape

ACCESS Newswire April 22, 2025

Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada

GlobeNewswire March 25, 2025

Mangoceuticals Announces the Launch of "PeachesRx" - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss Treatments

GlobeNewswire February 20, 2025

Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution

GlobeNewswire February 12, 2025

Mangoceuticals Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research

GlobeNewswire February 6, 2025

Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation

GlobeNewswire February 3, 2025

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent

GlobeNewswire December 19, 2024

Opinion & Analysis (NDAQ:MGRX)

No current opinion is available.

Bullboard Posts (NDAQ:MGRX)

Mangoceuticals, Inc. (MGRX): A Diversified Player in the Men

Interesting play in men's health market. MGRX looks like a speculative bet with some potential. Revenues are tiny at $510k for 9...
MikeTester - January 24, 2025

MGRX.....let's cut to the chase.....hurry up with the

P.O announcement Waiting patiently ; )
Iseneschal - October 1, 2024

RE:MGRX....will this turn into a Gree to Red move

Green*......sheesh
Iseneschal - October 1, 2024

MGRX....will this turn into a Gree to Red move

lots of resistance above and to 40 cents....next support is 20 cents Just my 2bits
Iseneschal - October 1, 2024

MGRX.....Well how do you like me so far?????

Re-read my last post Cheers !
Iseneschal - October 1, 2024

MGRX....Early a.m runner...but there is a reason ; )

Here is the fluff NR this a.m.....make sure you read my whole post ; ) MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch...
Iseneschal - October 1, 2024